The 36-month beta value for ABSI is at 2.07. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 4 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ABSI is 111.47M, and currently, shorts hold a 22.01% of that float. The average trading volume for ABSI on June 17, 2025 was 2.97M shares.
ABSI) stock’s latest price update
The stock price of Absci Corp (NASDAQ: ABSI) has dropped by -0.35 compared to previous close of 2.82. Despite this, the company has seen a fall of -7.26% in its stock price over the last five trading days. globenewswire.com reported 2025-05-20 that VANCOUVER, Wash. and NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative design, today announced the company will be participating in the following upcoming investor conferences.
ABSI’s Market Performance
Absci Corp (ABSI) has seen a -7.26% fall in stock performance for the week, with a -2.43% decline in the past month and a -8.77% plunge in the past quarter. The volatility ratio for the week is 3.05%, and the volatility levels for the past 30 days are at 2.85% for ABSI. The simple moving average for the past 20 days is 0.09% for ABSI’s stock, with a -18.04% simple moving average for the past 200 days.
Analysts’ Opinion of ABSI
Many brokerage firms have already submitted their reports for ABSI stocks, with Needham repeating the rating for ABSI by listing it as a “Buy.” The predicted price for ABSI in the upcoming period, according to Needham is $9 based on the research report published on January 22, 2025 of the current year 2025.
Guggenheim, on the other hand, stated in their research note that they expect to see ABSI reach a price target of $10. The rating they have provided for ABSI stocks is “Buy” according to the report published on October 02nd, 2024.
Morgan Stanley gave a rating of “Overweight” to ABSI, setting the target price at $7 in the report published on July 03rd of the previous year.
ABSI Trading at -2.06% from the 50-Day Moving Average
After a stumble in the market that brought ABSI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.61% of loss for the given period.
Stock Fundamentals for ABSI
Current profitability levels for the company are sitting at:
- -23.48 for the present operating margin
- -1.74 for the gross margin
The net margin for Absci Corp stands at -29.56. The total capital return value is set at -0.42. Equity return is now at value -48.98, with -42.37 for asset returns.
Based on Absci Corp (ABSI), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -9.27. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -275.45.
Currently, EBITDA for the company is -89.08 million with net debt to EBITDA at 0.41. When we switch over and look at the enterprise to sales, we see a ratio of 88.1. The receivables turnover for the company is 2.63for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.72.
Conclusion
In conclusion, Absci Corp (ABSI) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
